Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harjeet S Virk

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|January 29, 2019
Impact of antimicrobial therapy on the gut microbiomeAmira A Bhalodi, Tjitske S R van Engelen, Harjeet S Virk, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2020
What Sepsis Researchers Can Learn from COVID-19Michiel Schinkel, Harjeet S Virk, Prabath W B Nanayakkara, et al.
Infectious Diseases (London, England)|January 6, 2022
Epidemiology of sepsis and risk factors for mortality in intensive care unit: a hospital based prospective study in South IndiaRahul Garg, Chaitanya Tellapragada, Tushar Shaw, et al.
Nature Reviews. Disease Primers|February 2, 2018
MelioidosisW Joost Wiersinga, Harjeet S Virk, Alfredo G Torres, et al.
The Lancet. Infectious Diseases|July 10, 2019
Global burden of melioidosis in 2015: a systematic review and data synthesisEmma Birnie, Harjeet S Virk, Jelmer Savelkoel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2024
Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)Harjeet S Virk, Jason J Biemond, Venkat A Earny, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|January 29, 2019
Impact of antimicrobial therapy on the gut microbiomeAmira A Bhalodi, Tjitske S R van Engelen, Harjeet S Virk, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2020
What Sepsis Researchers Can Learn from COVID-19Michiel Schinkel, Harjeet S Virk, Prabath W B Nanayakkara, et al.
Infectious Diseases (London, England)|January 6, 2022
Epidemiology of sepsis and risk factors for mortality in intensive care unit: a hospital based prospective study in South IndiaRahul Garg, Chaitanya Tellapragada, Tushar Shaw, et al.
Nature Reviews. Disease Primers|February 2, 2018
MelioidosisW Joost Wiersinga, Harjeet S Virk, Alfredo G Torres, et al.
The Lancet. Infectious Diseases|July 10, 2019
Global burden of melioidosis in 2015: a systematic review and data synthesisEmma Birnie, Harjeet S Virk, Jelmer Savelkoel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2024
Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India)Harjeet S Virk, Jason J Biemond, Venkat A Earny, et al.
Pageof 1